These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9561467)

  • 1. Fungal infection in the intensive care unit.
    Flanagan PG; Barnes RA
    J Hosp Infect; 1998 Mar; 38(3):163-77. PubMed ID: 9561467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunistic fungal infections in the critically ill.
    Shelton BK
    Crit Care Nurs Clin North Am; 2000 Sep; 12(3):323-40. PubMed ID: 11855237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive fungal infection in critically ill patients].
    Garnacho-Montero J; Díaz-Martín A; Ruiz-Pérez De Piappón M; García-Cabrera E
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):338-43. PubMed ID: 22503211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
    Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
    Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive fungal infections in the ICU.
    Shoham S; Marwaha S
    J Intensive Care Med; 2010; 25(2):78-92. PubMed ID: 19955115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fungal infections in the intensive care unit].
    Kerwat K; Rolfes C; Wulf H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Nov; 46(11-12):744-5. PubMed ID: 22161906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of systemic candidal infections in the intensive care unit.
    Kam LW; Lin JD
    Am J Health Syst Pharm; 2002 Jan; 59(1):33-41. PubMed ID: 11813465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimycotic therapy on intensive care units: pro].
    Füssle R; Boldt J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):457-8. PubMed ID: 8297955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Occurrence of yeast infections at a surgical intensive care unit].
    Motycka V; Sákra L; Mencl K; Havlícek K
    Rozhl Chir; 2001 Jun; 80(6):320-3. PubMed ID: 11482157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role and importance of fungal infections in intensive care units].
    Tatić M; Stanić-Canji D; Drasković B; Komarcević A; Gajdobranski D
    Med Pregl; 2003; 56(11-12):537-41. PubMed ID: 15080046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Risk Prediction Model for Invasive Fungal Disease in Critically Ill Patients in the Intensive Care Unit.
    Li F; Zhou M; Zou Z; Li W; Huang C; He Z
    Asian Nurs Res (Korean Soc Nurs Sci); 2018 Dec; 12(4):299-303. PubMed ID: 30472388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida infections in non-neutropenic children after the neonatal period.
    Hacimustafaoglu M; Celebi S
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):923-40. PubMed ID: 21973304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.
    Rocco TR; Reinert SE; Simms HH
    Arch Surg; 2000 Feb; 135(2):160-5. PubMed ID: 10668874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of mycoses in intra-abdominal infections].
    Blinzler L; Fischer K; Just HM; Heuser D
    Langenbecks Arch Chir; 1997; 382(4 Suppl 1):S5-8. PubMed ID: 9333708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to select an antifungal agent in critically ill patients.
    Dimopoulos G; Antonopoulou A; Armaganidis A; Vincent JL
    J Crit Care; 2013 Oct; 28(5):717-27. PubMed ID: 24018296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimycotic therapy on intensive care units: contra].
    Dennhardt R; Gramm HJ; Wiegand-Löhnert C; Lode H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Nov; 28(7):453-6. PubMed ID: 8297954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Early detection and diagnosis of invasive mycoses].
    Kaben U
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):169-73. PubMed ID: 9606883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.